New User:

Forgot your password?

Stock Market & Financial Investment News

News Breaks
December 27, 2012
08:34 EDTPRXLPAREXEL raises Q2 GAAP EPS to 33c-34c from 31c-33c, consensus 32c
Raises Q2 revenue to $415M-$420M from $400M-$410M, consensus $405.08M.
News For PRXL From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
November 12, 2015
09:02 EDTPRXLPAREXEL, KPU announce joint program for clinical research
PAREXEL International Corporation and Kyoto Pharmaceutical University, or KPU, a private pharmacy and science university, today announced the new Joint Program for Clinical Research and Clinical Trial Management. The academic program offers undergraduate students an accredited, seven-week course designed to prepare them for careers in the biopharmaceutical industry. The collaboration is intended to meet the needs of a growing number of Japanese biopharmaceutical companies conducting clinical research inside and outside of Japan as part of global drug development initiatives. The course combines PAREXEL's extensive regulatory and clinical research expertise with Kyoto Pharmaceutical University's extensive experience developing highly-specialized research abilities in their "pharmacist-scientists" students. All classes will be conducted in English by non-Japanese lecturers from the PAREXEL Academy and are consistent with global clinical trial standards and practices. The first session begins in KPU's fiscal year 2016 and will be offered annually.

Sign up for a free trial to see the rest of the stories you've been missing.
I agree to the disclaimer & terms of use